Skip to content
10-Q

Quarterly Report

Sienna Biopharmaceuticals, Inc.

0001193125-19-290017

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 7, 2019 30.91M sh
Capex Q3 2019 · Sep 30, 2019 $4K
Capex Q3 2019 · Sep 30, 2018 $33K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$39.03M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$46.09M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $11.33M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $48.53M
Stockholders Equity Q3 2019 · Sep 30, 2019 $23.1M
Stockholders Equity Q3 2019 · Jun 30, 2019 $26.98M
Stockholders Equity Q3 2019 · Mar 31, 2019 $33.29M
Stockholders Equity Q3 2019 · Dec 31, 2018 $26.58M
Stockholders Equity Q3 2019 · Sep 30, 2018 $44.93M
Stockholders Equity Q3 2019 · Jun 30, 2018 $55.53M
Stockholders Equity Q3 2019 · Mar 31, 2018 $76.42M
Stockholders Equity Q3 2019 · Dec 31, 2017 $91.2M
Current Liabilities Q3 2019 · Sep 30, 2019 $1.29M
Current Liabilities Q3 2019 · Dec 31, 2018 $24.35M
Total Liabilities Q3 2019 · Sep 30, 2019 $20.39M
Total Liabilities Q3 2019 · Dec 31, 2018 $80.73M
Current Assets Q3 2019 · Sep 30, 2019 $19.73M
Current Assets Q3 2019 · Dec 31, 2018 $50.41M
Total Assets Q3 2019 · Sep 30, 2019 $43.49M
Total Assets Q3 2019 · Dec 31, 2018 $107.31M
Sga Expense Q3 2019 · Sep 30, 2019 $5.02M
Sga Expense Q3 2019 · Sep 30, 2019 $12.11M
Sga Expense Q3 2019 · Sep 30, 2018 $5.14M
Sga Expense restated Q3 2019 · Sep 30, 2018 $14.31M
Rd Expense Q3 2019 · Sep 30, 2019 $3.82M
Rd Expense Q3 2019 · Sep 30, 2019 $16M
Rd Expense Q3 2019 · Sep 30, 2018 $12.15M
Rd Expense Q3 2019 · Sep 30, 2018 $40.82M
Net Income Q3 2019 · Sep 30, 2019 −$3.97M
Net Income Q3 2019 · Sep 30, 2019 −$28.62M
Net Income Q3 2019 · Jun 30, 2019 −$8.26M
Net Income Q3 2019 · Mar 31, 2019 −$16.38M
Net Income Q3 2019 · Sep 30, 2018 −$16.79M
Net Income Q3 2019 · Sep 30, 2018 −$54.14M
Net Income Q3 2019 · Jun 30, 2018 −$20.24M
Net Income Q3 2019 · Mar 31, 2018 −$17.1M
Operating Income Q3 2019 · Sep 30, 2019 −$6.04M
Operating Income Q3 2019 · Sep 30, 2019 −$29.6M
Operating Income Q3 2019 · Sep 30, 2018 −$16.58M
Operating Income Q3 2019 · Sep 30, 2018 −$56.73M
Long Term Debt Q3 2019 · Dec 31, 2018 $30.13M